TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS revenue breakdown overview

TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS revenue for the last year amounted to 29.77 B USD, the most of which — 8.08 B USD — came from its highest performing source at the moment, Gastrointestinal, the year earlier bringing 7.79 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS 15.52 B USD, and the year before that — 15.26 B USD.